YM Bio. Com Shs Share Discussion Threads

[rambutan2] 10/3/2006 02:31

From SG Cowen ie the above link...

"Because of the magnitude of the data from the first trial, and because of what we now know about the mode of action of the drug, we are reasonably confident that we will have a successful trial and that those data will be available to us to file our NDA some time during 2006." said a confident sounding mr allen.

[rambutan2] 09/3/2006 02:23

listen to them at the big sg cowan healthcare conference later today...

[rambutan2] 09/3/2006 01:48

few snippet of conversation from 03/03/06 stateside, where tradeable options on ym have just been made available...

Over $1 million was bet today that YMI will be over $9 by October. The average call sold for $1.50, expiring in Oct for a $7.50 strike. The sell side was willing to take the $1.50 plus the possible $7.50 to receive $9 for stock they probably paid $4.25 for. Nice gain. The buy side thinks the stock will be sufficiently higher than $9 to risk $1 million aggregate by October.

Wow. (I was a writer of some of the puts today, the $5 strike July and October. If the results are delayed or poor, I'll have the stock put to me at around $3.30 to $3.50 net. That's an OK bet I think.)

Let me clarify that last post. I don't think it's amazing that the price would be over $9 at the tesmilifene announcement. I think it's amazing that such large bets were placed on the options expiring in July at the higher strike price. That is confidence that the news will be released when YMI said it would and that the news will be good and that the market will respond at a price sufficiently higher than $9 to make it a worthwhile bet to risk well over $1 million.

I prefer to just own the stock.

however...
the biggest bet today was the sell (at bid and below, $0.85 - 1.05 at 1.24PM) of 5000 contracts (ie 500k (!) shares) of 7.5 Jul calls; someone bets huge money this stock will be below 7.5 by July, or it's someone with big stock position, 50k shares or more, covering (personally, i don't believe that)

but...
Even if the stock is over $7.50, that seller will receive around $8.50 per share with the option premium. If they were one of the $4.25 secondary offering investors, that's a pretty good rate of return for a few months. Maybe they don't expect results by the July expiration date.

[rambutan2] 09/3/2006 01:17

some stateside coverage...


and some canada coverage...

[rambutan2] 22/2/2006 22:27

did bode well - up another 6% in states today to close at $5.48 (£3.14). i suspect that the more it becomes visible to the stateside investor the more it is being recognised as way undervalued compared to peers and that the climb will continue.

although of course bad news from the tesmilifene phase III would bring things to a juddering halt.

[rambutan2] 22/2/2006 01:39

closed back above $5 in states.

so, a quick recovery from last week's placing. bodes well...

[rambutan2] 15/2/2006 11:49

for the record, yesterday it closed at equiv of £2.69 in states and £2.70 in canada. the mms here settled on £2.65-£2.85. will be interesting to see what mkt decides to do today, having had a night to sleep on it.

[rambutan2] 14/2/2006 14:47

no complaints at $4.25 ie £2.45...

YM BioSciences raises US $ 40 million
Tuesday February 14, 9:31 am ET

MISSISSAUGA, Canada, Feb. 14 /PRNewswire-FirstCall/ - YM BioSciences Inc. (AMEX:YMI, TSX:YM, AIM:YMBA), the cancer product development company, today announced that it has received subscriptions for approximately 9.5 million common shares in a "registered direct" offering at an issue price of US $4.25 for gross proceeds of approximately US $40 million. SG Cowen & Co., LLC served as lead placement agent and Dundee Securities Corporation and Canaccord Capital Corporation served as co-placement agents for the transaction.

The funds will be used principally to fund YM's drug development activities and for general corporate purposes.

Subscribers for the issue included leading health care institutional investors led by Great Point Partners, LLC

The transaction is expected to close on or about February 17, 2006, pending stock exchange approval.

[mikkydhu] 14/2/2006 14:37

Raising US$40m.

[mikkydhu] 13/2/2006 18:13

Yup, Ramb. as of today. Wish I'd cottoned on sooner. In spite of the rocket shaped graph, I reckon it's got a long way to go. Much talk on Yahoo message boards of how interesting its pipeline could be to a big pharma. Thanks for this thread and your contributions to it. Cheers, M.

[mikkydhu] 13/2/2006 14:31

News today that tesmilifene is to be fast-tracked.

[Abuse team] 13/2/2006 00:52

Post removed by ADVFN

[rambutan2] 12/2/2006 23:25

The new copy of Barrons listed YMI as the second biggest % gainer on the AMEX. Bound to attract some extra pi interest.

[rambutan2] 10/2/2006 22:56

closed at $5.02 in states - what a slam dunk week. and perhaps it's only the start...

[rambutan2] 10/2/2006 11:40

good lord, the second aim buy of the week - mms must be getting nervous!

anyone care to own up?

or post here!

[Abuse team] 10/2/2006 05:15

Post removed by ADVFN

[rambutan2] 10/2/2006 01:56

closed up another 5% in states at $4.70. looking like it's set to break $5.

[rambutan2] 09/2/2006 10:03

mms on the ball here now and opened it at 240-260p.

what a stonking looking chart we've now got.

that piece in business week has attracted plenty of attention in the states.

on robtv last night a bio analyst talked about ym and gave it "star buy" status...

6:00 PM ET
Stars & Dogs
Investors and the Nortel Settlement; Going Fishing for Biotech Bargains; Andy's Flying an Airline Dog
Douglas Loe, healthcare and biotech analyst, Versant Partners

Duration: 27 m 32 s

[rambutan2] 07/2/2006 09:51

mms keep having to play catch up with states/canada close. pity the price never appears on the advfn toplists.

08/02 update: closed at equiv of 250p in canada and 258p in states.

[Abuse team] 07/2/2006 01:37

Post removed by ADVFN